A1C improvements curb 5-year mortality risk in diabetes

10/18/2012 | InternalMedicineNews.com

Data on 12,359 type 2 diabetes patients with poor glucose control revealed those who showed A1C improvements were less likely to die of any cause within five years compared with those who had no improvement in glucose levels. Participants with improved A1C were also less likely than those with poor glycemic control to develop coronary heart disease and experience fatal cardiovascular disease, researchers noted. The results were presented at the European Association for the Study of Diabetes meeting.

View Full Article in:

InternalMedicineNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA